[1]CurrentPatentAssignee:THEJOHNSHOPKINSUNIVERSITY-WO2013/149026,2013,A2
[1]CurrentPatentAssignee:THEJOHNSHOPKINSUNIVERSITY-WO2013/149026,2013,A2
[2]CurrentPatentAssignee:AMGENINC-US2013/323198,2013,A1
[3]CurrentPatentAssignee:AMGENINC-WO2015/84649,2015,A1
[4]Geuns-Meyer,Stephanie;Cee,VictorJ.;Deak,HollyL.;Du,Bingfan;Hodous,BrianL.;Nguyen,HanhNho;Olivieri,PhilipR.;Schenkel,LaurieB.;Vaida,KarinaR.;Andrews,Paul;Bak,Annette;Be,Xuhai;Beltran,PedroJ.;Bush,TammyL.;Chaves,MaryK.;Chung,Grace;Dai,Yang;Eden,Patrick;Hanestad,Kelly;Huang,Liyue;Lin,Min-HwaJasmine;Tang,Jin;Ziegler,Beth;Radinsky,Robert;Kendall,Richard;Patel,VinodF.;Payton,Marc[JournalofMedicinalChemistry,2015,vol.58,#13,p.5189-5207]
[5]CurrentPatentAssignee:AMGENINC-EP2818170,2018,B1
[1]CurrentPatentAssignee:AMGENINC-WO2015/84649,2015,A1Locationinpatent:Page/Pagecolumn20;21
[2]Geuns-Meyer,Stephanie;Cee,VictorJ.;Deak,HollyL.;Du,Bingfan;Hodous,BrianL.;Nguyen,HanhNho;Olivieri,PhilipR.;Schenkel,LaurieB.;Vaida,KarinaR.;Andrews,Paul;Bak,Annette;Be,Xuhai;Beltran,PedroJ.;Bush,TammyL.;Chaves,MaryK.;Chung,Grace;Dai,Yang;Eden,Patrick;Hanestad,Kelly;Huang,Liyue;Lin,Min-HwaJasmine;Tang,Jin;Ziegler,Beth;Radinsky,Robert;Kendall,Richard;Patel,VinodF.;Payton,Marc[JournalofMedicinalChemistry,2015,vol.58,#13,p.5189-5207]
[3]CurrentPatentAssignee:THEJOHNSHOPKINSUNIVERSITY-WO2013/149026,2013,A2Locationinpatent:Page/Pagecolumn13
[4]CurrentPatentAssignee:AMGENINC-US2013/323198,2013,A1Locationinpatent:Paragraph0049
[5]CurrentPatentAssignee:AMGENINC-EP2818170,2018,B1Locationinpatent:Paragraph0032;0036
Title: Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon Resonance.
Journal: Journal of molecular biology 20170217
Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: Gender effects on rat metabolism of AMG 900, an orally available small molecule aurora kinase inhibitor.
Journal: Drug metabolism letters 20111201
Title: In vitro and in vivo pharmacokinetic characterizations of AMG 900, an orally bioavailable small molecule inhibitor of aurora kinases.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20110501
Title: Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines.
Journal: Cancer research 20101201
Title: Payton M, et al. Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines. Cancer Res, 2010, 70(23), 9846-9854.
Title: Juan G, et al. AMG 900, a potent inhibitor of aurora kinases causes pharmacodynamic changes in p-Histone H3 immunoreactivity in human tumor xenografts and proliferating mouse tissues. J Transl Med. 2014 Nov 4;12:307.
Title: Huang L, et al. In vitro and in vivo pharmacokinetic characterizations of AMG 900, an orally bioavailable small molecule inhibitor of aurora kinases. Xenobiotica. 2011 May;41(5):400-8.
